LEVOTREAT

This brand name is authorized in Nigeria.

Active ingredients

The drug LEVOTREAT contains one active pharmaceutical ingredient (API):

1	Levofloxacin UNII 6GNT3Y5LMF - LEVOFLOXACIN
	Levofloxacin is a synthetic antibacterial agent of the fluoroquinolone class. As a fluoroquinolone antibacterial agent, levofloxacin acts on the DNA – DNA-gyrase complex and topoisomerase IV.
	Read more about Levofloxacin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-0919	Tablet	LEVOTREAT 500MG TABLET TAB 500 mg 1 X 10	68 RNW-PP-169596 LEVOTREAT 500MG TABLET LEVOFLOXACIN ACTIVE: LEVOFLOXACIN HEMIHYDRATE, EQ. TO LEVOFLOXACIN 500MG LIST OF EXCIPIENTS: (1) Crospovidone (2) Hypromellose (3) Microcrystalline cellulose (4) Sodium stearyl fumarate. B4-0919 Drugs ANTIINFECTIVES FOR SYSTEMIC USE Imported Products 110 Prescription Only Medicine (POM) 12/13/2021 VITBORAH PHARM COMPANY LIMITED, LAYI OYEKANMI STREET , MUSHIN ISOLO LAGOS 7036395409 vitborahpharma@gmail.com BRUSSELS LABORATORIES PVT LTD, NO. 33, CHANGODAR INDUSTRIAL ESTATE, SARKEJ- BAVLA ROAD, CHANGODA-382210 DIS AHMEDABAD, GUJARAT,INDIA., India	28/03/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01MA12	Levofloxacin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01M Quinolone antibacterials → J01MA Fluoroquinolones
Discover more medicines within J01MA12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-0919